Literature DB >> 15213271

Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies.

Takao Masaki1, Cosimo Stambe, Prudence A Hill, John Dowling, Robert C Atkins, David J Nikolic-Paterson.   

Abstract

Examined was extracellular-signal regulated kinase (ERK) activation in normal human kidney (n = 2) and a cohort of glomerulopathies by immunohistochemistry staining for the dual-phosphorylated form of ERK (p-ERK). Cell proliferation was determined by expression of the proliferating cell nuclear antigen (PCNA). In normal human kidney, p-ERK was largely restricted to the cytoplasm of cells of the collecting duct (CD). In glomerulopathies, glomerular ERK activation was highly variable. However, there was colocalization of cell proliferation and ERK activation in the glomerular tuft and crescents. Tubular ERK activation in the different glomerulopathies was confined to the CD in areas with normal architecture. In contrast, ERK activation was prominent in tubules and interstitial cells in areas of tubulointerstitial damage. ERK activation was observed in glomerular and interstitial alpha-smooth muscle actin-positive myofibroblasts, but few macrophages or T cells showed ERK activation. There was a significant correlation between glomerular p-ERK+ and PCNA+ cells and between tubular p-ERK+ and PCNA+ cells. Glomerular p-ERK+ cells correlated with glomerular cellularity and the percentage of glomeruli with segmental lesions. Tubular p-ERK+ cells correlated with renal dysfunction and interstitial fibrosis and tubular atrophy. In conclusion, activation of the ERK pathway in human glomerulopathies correlates with cell proliferation, histologic lesions, and renal dysfunction. ERK activation may promote renal repair through tubular proliferation while promoting renal fibrosis via proliferation of glomerular and interstitial myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213271     DOI: 10.1097/01.asn.0000130623.66271.67

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  24 in total

Review 1.  Organization of the ENaC-regulatory machinery.

Authors:  Rama Soundararajan; Ming Lu; David Pearce
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-04-16       Impact factor: 8.250

2.  The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Authors:  Petros Andrikopoulos; Julius Kieswich; Sabrina Pacheco; Luxme Nadarajah; Steven Michael Harwood; Caroline E O'Riordan; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2018-12-10       Impact factor: 10.121

3.  Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.

Authors:  B Faria; C Henriques; A C Matos; M R Daha; M Pestana; M Seelen
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

4.  A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats.

Authors:  S D Proctor; S E Kelly; J C Russell
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 5.  Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells.

Authors:  M Bens; C Chassin; A Vandewalle
Journal:  Pflugers Arch       Date:  2006-08-26       Impact factor: 3.657

Review 6.  The role of the ENaC-regulatory complex in aldosterone-mediated sodium transport.

Authors:  Rama Soundararajan; David Pearce; Tim Ziera
Journal:  Mol Cell Endocrinol       Date:  2011-11-12       Impact factor: 4.102

7.  Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.

Authors:  Stergios J Moschos; Ryan J Sullivan; Wen-Jen Hwu; Ramesh K Ramanathan; Alex A Adjei; Peter C Fong; Ronnie Shapira-Frommer; Hussein A Tawbi; Joseph Rubino; Thomas S Rush; Da Zhang; Nathan R Miselis; Ahmed A Samatar; Patrick Chun; Eric H Rubin; James Schiller; Brian J Long; Priya Dayananth; Donna Carr; Paul Kirschmeier; W Robert Bishop; Yongqi Deng; Alan Cooper; Gerald W Shipps; Blanca Homet Moreno; Lidia Robert; Antoni Ribas; Keith T Flaherty
Journal:  JCI Insight       Date:  2018-02-22

8.  A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension.

Authors:  Jingfei Cheng; Wei Zhou; Gina M Warner; Bruce E Knudsen; Vesna D Garovic; Catherine E Gray; Lilach O Lerman; Jeffrey L Platt; J Carlos Romero; Stephen C Textor; Karl A Nath; Joseph P Grande
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-22

10.  Epithelial sodium channel regulated by differential composition of a signaling complex.

Authors:  Rama Soundararajan; Daniël Melters; I-Chia Shih; Jian Wang; David Pearce
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.